Bioprocess Analysers Market By Product (Instruments and Consumables) By Application (Antibiotics, Recombinant Proteins, Biosimilars and Other Applications) By Type (Substrate Analysis, Metabolite Analysis and Concentration Detection)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Key Highlights of the report

How are the major segments performing in the bioprocess analysers market?

• In 2022, the consumables category accounted for the largest share of the market. This is due to the introduction of new products and the increased effectiveness of various mediums used to produce cell cultures.
• In 2022, the recombinant proteins category held a largest share. Recombinant proteins are increasingly needed for medical applications and studies on protein-protein interactions, making it possible to conduct various diagnostic tests like ELISA and IHC.
• In 2022, the substrate analysis category held a largest share. Bioprocess analyzers are frequently used for substrate analysis, a crucial component of bioprocess monitoring. A substrate analysis measures the concentration of the substrates ingested by microorganisms during a bioprocess.

What is the market size of bioprocess analysers regarding value?

The global bioprocess analysers market is anticipated to grow at a substantial CAGR of 10.90% in the upcoming years. The global bioprocess analysers industry was estimated to be worth USD 0.4 billion in 2022 and was expected to be worth USD 0.8 billion by 2028.

Which region dominated the bioprocess analysers market?

In 2022, the North American region was anticipated to hold a prominent share of the global bioprocess analysers market. The growth of important businesses in the region and increased R&D in sectors like biotechnology and pharmaceuticals are to blame. The opening of manufacturing facilities, partnerships, and acquisitions indicating a rise in the output of 2D manufacturing bags will also help the market grow. In addition, ferocious competition and a change in contract research organizations are propelling the regional market for bioprocess analyzers to grow.

How US market is performing in the bioprocess analysers market?

In 2022, the United States was anticipated to hold a prominent share in the global bioprocess analysers market in North American region. The market in this area is anticipated to be driven by increased mergers and acquisitions among contract research organizations in the United States. For instance, in March 2021, the US HHS and Merck worked together to repurpose Merck’s current facilities for the quick, mass production of pharmaceuticals and vaccines for use in public health emergencies, such as the COVID-19 pandemic. As a result, as bioprocess bags are primarily used to produce vaccines, the government’s efforts to improve vaccine production in the nation will increase demand for them and drive the market. Therefore, these agreements and investments made by important stakeholders to increase vaccine manufacturing in the nation show that vaccination demand is rising.

How is the economy impacting the global bioprocess analysers growth?

The pandemic impacted the market. Bioprocess containers manufacture vaccines for various reasons, including high titer, consistent product quality, the resilience of the process, quick turnaround times, and scalability. Research on the COVID-19 vaccine is being conducted by numerous businesses, using their products. The market under investigation is anticipated to eventually reach its full potential due to widespread immunization campaigns worldwide and fresh financial investments in the biopharmaceutical sector.

What is the competitive environment of the bioprocess analysers market?

There are several significant competitors in the fairly competitive market for bioprocess analyzers. The major firms’ varied competitive strategies include key mergers and acquisitions, technological advances, and product marketing to maintain the global bioprocess analyzers market. For instance, in August 2022, to develop an automated, online system for bioprocess culture monitoring and control, Flownamics and Beckman Coulter Life Sciences partnered to develop the solution. The Seg-Flow S3 Automated On-Line Sampling System from Flownamics and the company’s Vi-CELL BLU Cell Viability Analyzer are combined through collaboration.

Executive Summary

What are the key trends in the bioprocess analysers market?

• Growing Demand for Biopharmaceuticals to Support Market Development: The sector is fueled by the rising need for and manufacturing of biopharmaceuticals such recombinant proteins, vaccines, and other products that use the bioprocess, such as recombinant proteins and others. Additionally, the business is being revolutionized by the growth of the pharmaceutical industry and the rising prevalence of chronic disorders. The sector is expanding due to the rising demand for vaccines and the quick development of technologies. In the upcoming years, the industry is anticipated to benefit greatly from the rising government assistance for biofuel production in several nations. Leading biotech and pharmaceutical businesses are anticipated to make large investments during the forecast period, which would help the market develop even more.

How the market has expanded as a result of the increased interest in the creation of cutting-edge drugs and vaccines?

The increasing demand for biologics and the growing interest in creating cutting-edge drugs and vaccines are the main drivers of market expansion. The market’s growth is anticipated to be accelerated by these factors. Chronic diseases are more common among the aging population, driving up demand for biologics. Myocardial infarction (MI) is a significant occurrence in cardiovascular illness, one of the main causes of death worldwide. The National Library of Medicine reported in a March 2021 paper that current therapeutics do not properly address the several dysregulated systems accompanying MI. Over the projected period, more research is anticipated to create drug delivery methods for biologics, which would help the market expand.

Which are the key investments by the bioprocess analysers market players?

The expansion of the market is being driven by the key market participants’ growing investments in the creation of biologics. Aurobindo Pharma (CuraTeQ Biologics) announced plans in 2022 to invest over INR 300 crore in the capacity expansion of biologics production facilities. This plant is anticipated to be completely operational by 2026. As a result, such partnerships and investments by important players to increase vaccine production show the rising need for vaccinations. The market is anticipated to grow due to increased production of bioprocess containers to meet this demand.

Major bioprocess analyzers market players are 4BioCell GmbH & Co. KG, Agilent Technologies, F. Hoffmann-La Roche AG, Groton Biosystems, Kaiser Optical Systems Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Sartorious AG, SYSBIOTECH GmbH, Thermo Fisher Scientific and YSI Inc.

What are the major driving factors for the bioprocess analysers market?

The major reasons propelling the growth of the life sciences industry, pharmaceutical and biotechnology businesses’ emphasis on research and development, and technological advancements in bioprocess analyzers. Producers looking for big production numbers also have opportunities. Most stainless steel facilities are currently being constructed in developing countries to suit the high volume demand in the global bioprocess analyzers market. Even if stainless steel facilities are rapidly disappearing due to the popularity explosion of single-use technology, there will still be chances in the global market for bioprocess analyzers. Throughout the forecast period, it is predicted that technological advancements and mergers & acquisitions will drive growth in the global market for bioprocess analyzers.

What are the major risks for the bioprocess analysers market?

One of the key factors that is anticipated to hinder the growth of the global bioprocess analyzer market is that bioprocess takes longer than chemical process methods. Another element that is anticipated to restrain the growth of the global bioprocess analyzer market is challenges related to downstream bioprocess. For instance, some of the main challenges of downstream bioprocess that biopharma researchers typically encounter include increased volume, cell densities, and protein masses. Small-scale bioprocessing equipment also makes it difficult to cleanse the drug or material. The small-scale bioprocessing equipment and the relatively high cost of the raw materials provide challenges during the upstream and downstream process, which restrain market expansion.

Which is the key application category in the bioprocess analysers market?

The recombinant proteins category held the largest share of the market in 2022. Recombinant DNA is used to insert DNA encoding a protein into bacterial or mammalian cells, resulting in recombinant proteins. Following its expression in these cells, the protein is further purified. Either molecular cloning or the polymerase chain reaction is used to create recombinant proteins. (PCR). The main drivers of the market’s expansion are the market participants’ strategic initiatives, which include collaborations, approvals, and expanding R&D endeavors. The USFDA issued a Complete Response Letter (CRL) for the somatrogon Biologics License Application (BLA) in March 2022, according to reports from Pfizer Inc. and OPKO Health Inc.

How is the bioprocess analysers market performing in regions?

Asia Pacific market is anticipated to witness fastest growth in the global bioprocess analysers market during the forecast period. One of the key elements driving market expansion in the area is the expanding biopharmaceutical sector. Furthermore, the rising government backing from developing nations like China and India is assisting with increasing investment in the bioprocess analyzer market. Additionally, the region’s market is growing due to rising expenditure by leading market participants in R&D and growing demand for superior quality biologics to treat various ailments.

What is the regulatory landscape for the bioprocess analysers market?

It is anticipated that the increased funding from governments and businesses in the public and private sectors for developing new bioprocessing-based technologies and pharmaceuticals will open up attractive growth prospects for the global economy. Additionally, the key competitors use a variety of growth tactics, including joint ventures, mergers and acquisitions, licensing activities, collaborations, and government partnerships, which help to expand the global bioprocess analyzers market.

What are the major players planning for the future of the bioprocess analysers market?

The major players’ increased introduction of new technologies is anticipated to drive considerable growth in the global bioprocess analyzer market in the upcoming years. For instance, 908 Devices, a producer of analytical tools for chemical and bimolecular analysis, introduced Rebel in August 2019. Rebel is a cell media analyzer for bioprocess labs that assists biopharma researchers by doing media analysis at line speed to quicken the process development cycle and maximize bioreactor utilization. (production). Additionally, Rebel assists in identifying amino acids, biogenic amines, and water-soluble vitamins and their analysis.

Segmentation of Global Bioprocess Analysers Market-

Global Bioprocess Analysers Market – By Product

• Instruments
• Consumables

Global Bioprocess Analysers Market – By Application

• Antibiotics
• Recombinant Proteins
• Biosimilars
• Other Applications

Global Bioprocess Analysers Market – By Type

• Substrate Analysis
• Metabolite Analysis
• Concentration Detection

Global Bioprocess Analysers Market – By Region

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa